CHMP enedes derfor om, at der i sikkerhedsdataene ikke var tegn på, at sikkerhedsprofilen for ciprofloxacin ved længere tids anvendelse i op til 3 måneder skulle være berørt.
Therefore, the CHMP agreed that the safety data did not show any evidence that the safety profile of ciprofloxacin is affected by a longer treatment duration up to 3 months.